NRX:CC News and Press, NurExone Biologic Inc. From 08/09/22

Calgary, Alberta--(Newsfile Corp. - August 9, 2022) - NurExone Biologic Inc. (TSXV: NRX) (formerly, EnerSpar Corp.) (the " Company " or " NurExone "), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spine injuries, released excerpts fr...

Calgary, Alberta--(Newsfile Corp. - July 25, 2022) - NurExone Biologic Inc. (TSXV: NRX) ("NurExone" or the "Company"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other Central Nervous System ("CNS") indications, is...

Calgary, Alberta--(Newsfile Corp. - July 19, 2022) - NurExone Biologic Inc.  (TSXV: NRX)  (formerly, EnerSpar Corp.)   (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal injuries and other ...

Polyrizon will be entitled for up to $3.35 million in addition to future royalties Tel Aviv, Israel, July 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle ...

Developing the first-of-its-kind technology drug platform for a bio-guided exosome-based product known as ExoTherapy to treat trauma to the spinal cord, brain and other central nerve system indications Global spinal cord injury therapeutics market expected to reach US$9.61 billion by 2028 E...

"ExoTherapy", NurExone's proprietary Exosome siRNA loaded product, is being developed to recover functionality in patients with traumatic spinal cord injuries Calgary, Alberta--(Newsfile Corp. - July 11, 2022) - NurExone Biologic Inc.  (TSXV: NRX)  (formerly, EnerSpar Corp.)   ...

Bnei-Brak, Israel--(Newsfile Corp. - July 7, 2022) - NurExone Biologic Inc. (TSXV: NRX) ("NurExone" or the "Company"), a leading pharmaceutical company that develops innovative exosome-based treatments, is pleased to announce that the Company will host an investor webinar on Thursday, July 14,...

Bnei-Brak, Israel--(Newsfile Corp. - July 6, 2022) - NurExone Biologic Inc.  (TSXV: NRX)  (formerly, EnerSpar Corp.)   (" NurExone " or the " Company ") is pleased to announce that it has retained the services of Thesis Capital Inc. (" Thesis ") of Toronto, Ontario, a leading ca...

NurExone Biologic Inc. Opens the Market Canada NewsWire TORONTO , July 4, 2022 /CNW/ - Representatives from NurExone Biologic Inc. ("NurExone" or the "Company") (TSXV: NRX) and their team joined Yossi Boker , TMX Head of Business Development, Israel...

Bnei-Brak, Israel--(Newsfile Corp. - June 22, 2022) - NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (" NurExone " or the " Company ") is pleased to announce that, further to its press release of June 15, 2022 announcing the closing of its reverse takeover transaction, it wi...